Share on StockTwits

Shares of Immunomedics (NASDAQ:IMMU) traded down 5.9% during trading on Tuesday following a dissappointing earnings announcement, Analyst RN reports. The stock traded as low as $3.31 and last traded at $3.35, with a volume of 416,878 shares trading hands. The stock had previously closed at $3.56.

The company reported ($0.13) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.12) by $0.01. The company had revenue of $1.20 million for the quarter, compared to the consensus estimate of $1.20 million.

The stock’s 50-day moving average is $3.37 and its 200-day moving average is $3.89. The company’s market cap is $280.6 million.

Immunomedics, Inc is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.